Structures by: Kansiz S.
Total: 31
<i>catena</i>-poly[[[(<i>N</i>,<i>N</i>-diethylethylenediamine-\ κ^2^<i>N</i>,<i>N</i>')copper(II)]-μ-succinato-\ κ^2^<i>O</i>^1^:<i>O</i>^4^] tetrahydrate]
C10H20CuN2O4,4(H2O1)
Acta Crystallographica Section C (2017) 73, 7 517-524
a=15.7523(8)Å b=7.1201(3)Å c=15.9540(8)Å
α=90° β=112.709(4)° γ=90°
(<i>E</i>)-2-{[(2-Iodophenyl)imino]methyl}-6-methylphenol
C14H12INO
Acta Crystallographica Section E (2020) 76, 10 1595-1598
a=8.1730(4)Å b=11.8143(9)Å c=13.1721(8)Å
α=90° β=90° γ=90°
<i>catena</i>-Poly[[[(<i>N</i>,<i>N</i>,<i>N</i>,<i>N</i>'-tetramethylethylenediamine-κ^2^<i>N</i>,<i>N</i>')copper(II)]-μ-succinato-κ^2^<i>O</i>^1^:<i>O</i>^4^] tetrahydrate]
C10H20CuN2O4,4(H2O)
Acta Crystallographica Section E (2020) 76, 7 1038-1041
a=7.1195(4)Å b=12.3172(6)Å c=19.8590(12)Å
α=90° β=91.160(5)° γ=90°
Hexyl 1-hexyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C22H31NO3
Acta Crystallographica Section E (2020) 76, 5 642-645
a=17.6928(7)Å b=13.2512(5)Å c=8.5916(3)Å
α=90° β=90.184(2)° γ=90°
2-Amino-3-hydroxypyridin-1-ium 6-methyl-2,2,4-trioxo-2<i>H</i>,4<i>H</i>-1,2,3-oxathiazin-3-ide
C4H4NO4S1,C5H7N2O1
Acta Crystallographica Section E (2020) 76, 4 572-575
a=7.1676(5)Å b=9.1175(7)Å c=10.1554(8)Å
α=66.174(6)° β=80.225(6)° γ=71.803(6)°
Diaquabis(ethylenediamine-κ^2^<i>N</i>,<i>N</i>)copper(II) bis(2-nitrobenzoate)
2(C7H4NO4),C4H20CuN4O2
Acta Crystallographica Section E (2020) 76, 1 111-114
a=26.7742(16)Å b=20.8916(14)Å c=8.4254(5)Å
α=90° β=93.460(3)° γ=90°
(2,2-Bipyridine-κ^2^<i>N</i>,<i>N</i>')bis(2-methoxyethyl xanthato-κ<i>S</i>)zinc(II)
C18H22N2O4S4Zn
Acta Crystallographica Section E (2019) 75, 12 1857-1860
a=22.869(4)Å b=8.3212(12)Å c=12.5627(19)Å
α=90° β=115.348(4)° γ=90°
2,2'-{(1<i>E</i>,1'<i>E</i>)-[Ethane-1,2-diylbis(azanylylidene)]bis(methanylylidene)}bis[4-(trifluoromethoxy)phenol]copper(II) hydroquinone hemisolvate
C18H12CuF6N2O4,0.5(C6H6O2)
Acta Crystallographica Section E (2019) 75, 11 1729-1733
a=9.3167(10)Å b=10.0363(10)Å c=11.8052(13)Å
α=92.633(9)° β=97.310(9)° γ=98.670(9)°
4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2<i>H</i>)-one
C17H14N2O
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=10.819(3)Å b=11.501(3)Å c=11.187(4)Å
α=90° β=90.93(3)° γ=90°
Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate
C20H16Cl2N2O3
Acta Crystallographica Section E (2019) 75, 11 1679-1684
a=11.2730(13)Å b=12.3808(9)Å c=14.1405(15)Å
α=90° β=92.801(9)° γ=90°
Bis(2-methoxyethyl xanthato-κ<i>S</i>)(<i>N</i>,<i>N</i>,<i>N</i>,<i>N</i>'-\ tetramethylethylenediamine-κ^2^<i>N</i>,<i>N</i>')zinc(II) acetone hemisolvate
C14H30N2O4S4Zn,0.5(C3H6O)
Acta Crystallographica Section E (2019) 75, 11 1582-1585
a=9.604(3)Å b=22.785(6)Å c=11.374(3)Å
α=90° β=106.304(12)° γ=90°
<i>N</i>-(<i>tert</i>-butyl)-2-(phenylethynyl)imidazo[1,2-<i>a</i>]pyridin-3-\ amine
C19H19N3
Acta Crystallographica Section E (2019) 75, 10 1564-1567
a=9.3492(2)Å b=16.3716(3)Å c=10.8030(2)Å
α=90° β=90° γ=90°
7-Methoxy-5-methyl-2-phenyl-11,12-dihydro-5,11-methano-1,2,4-triazolo[1,5-<i>c</i>][1,3,5]benzoxadiazocine
C19H18N4O2
Acta Crystallographica Section E (2018) 74, 9 1211-1214
a=13.9787(9)Å b=21.5654(12)Å c=11.6625(8)Å
α=90° β=111.639(5)° γ=90°
<i>N</i>,<i>N</i>'-Bis(3-<i>tert</i>-butyl-2-hydroxy-5-methylbenzylidene)ethane-1,2-diamine
C26H36N2O2
Acta Crystallographica Section E (2018) 74, 8 1147-1150
a=13.1124(14)Å b=9.8498(6)Å c=19.737(2)Å
α=90° β=106.892(8)° γ=90°
4-[4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)phenoxy]phthalonitrile monohydrate
C21H12N4O,H2O
Acta Crystallographica Section E (2018) 74, 7 994-997
a=8.7657(6)Å b=27.285(2)Å c=14.6938(13)Å
α=90° β=90° γ=90°
5-[(5-Nitro-1<i>H</i>-indazol-1-yl)methyl]-3-phenyl-4,5-dihydroisoxazole
C17H14N4O3
Acta Crystallographica Section E (2019) 75, 1 71-74
a=7.8595(4)Å b=11.8831(7)Å c=15.5716(9)Å
α=90° β=101.8530(10)° γ=90°
<i>N</i>,<i>N</i>'-[Ethane-1,2-diylbis(oxy)]bis(4-methylbenzenesulfonamide)
C16H20N2O6S2
Acta Crystallographica Section E (2019) 75, 1 81-85
a=16.3393(18)Å b=13.4977(19)Å c=9.7461(11)Å
α=90° β=113.442(8)° γ=90°
4-Dichloromethyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one
C10H8Cl2N2O
Acta Crystallographica Section E (2019) 75, 1 33-37
a=12.1783(6)Å b=5.7217(3)Å c=14.8258(7)Å
α=90° β=95.7400(10)° γ=90°
(<i>E</i>)-2,4-di-<i>tert</i>-butyl-6-[(3-chloro-4-methylphenylimino)methyl]phenol
C22H28ClNO
Acta Crystallographica Section E (2018) 74, 12 1887-1890
a=9.6753(10)Å b=7.0072(6)Å c=15.3749(13)Å
α=90° β=93.425(7)° γ=90°
(<i>E</i>)-1-[(4,7-Dimethylquinolin-2-yl)methylidene]semicarbazide dihydrate
C13H14N4O,2(H2O)
Acta Crystallographica Section E (2018) 74, 11 1674-1677
a=10.4731(7)Å b=7.4612(5)Å c=18.4906(14)Å
α=90° β=94.201(6)° γ=90°
(<i>E</i>)-<i>N</i>-[(2-Ethoxynaphthalen-1-yl)methylidene]-5,6,7,8-tetrahydronaphthalen-1-amine
C23H23NO
Acta Crystallographica Section E (2018) 74, 10 1513-1516
a=12.6628(4)Å b=20.3304(9)Å c=7.3838(3)Å
α=90° β=104.895(3)° γ=90°
2-Ammoniumylmethyl-1<i>H</i>-benzimidazol-3-ium chloride monohydrate
C8H11N3,Cl2,H2O,
Acta Crystallographica Section E (2018) 74, 10 1517-1520
a=6.9340(4)Å b=12.1198(7)Å c=19.2128(11)Å
α=99.859(5)° β=90.647(5)° γ=90.247(5)°
9-Bromo-2,5-dimethyl-11,12-dihydro-5<i>H</i>-5,11-methanobenzo[<i>g</i>][1,2,4]triazolo[1,5-<i>c</i>][1,3,5]oxadiazocine
C13H13BrN4O
Acta Crystallographica Section E (2019) 75, 4 492-498
a=6.1446(6)Å b=9.7407(8)Å c=11.6801(11)Å
α=109.657(7)° β=92.325(8)° γ=91.664(7)°
7-Methoxy-5-methyl-2-(pyridin-4-yl)-11,12-dihydro-5<i>H</i>-5,11-methanobenzo[<i>g</i>][1,2,4]triazolo[1,5-<i>c</i>][1,3,5]oxadiazocine
C18H17N5O2
Acta Crystallographica Section E (2019) 75, 4 492-498
a=11.2814(6)Å b=12.6299(6)Å c=22.0008(15)Å
α=90° β=90° γ=90°
<i>N</i>-{2-[(<i>E</i>)-(4-Methylbenzylidene)amino]phenyl}-2-(5-methyl-1-<i>H</i>-pyrazol-3-yl)acetamide hemihydrate
C20H20N4O,0.5(H2O)
Acta Crystallographica Section E (2019) 75, 2 154-158
a=11.546(3)Å b=12.564(3)Å c=13.172(3)Å
α=101.991(3)° β=97.535(3)° γ=99.847(3)°
(<i>Z</i>)-6-[(2-Hydroxy-5-nitroanilino)methylidene]-4-methylcyclohexa-2,4-dien-1-one
C14H12N2O4
Acta Crystallographica Section E (2019) 75, 6 812-815
a=6.0052(4)Å b=7.8206(5)Å c=26.2985(19)Å
α=90° β=90.303(5)° γ=90°
(<i>Z</i>)-6-[(2-Hydroxy-4-methylanilino)methylidene]-4-methylcyclohexa-2,4-dien-1-one
C15H15NO2
Acta Crystallographica Section E (2019) 75, 6 785-788
a=11.3954(19)Å b=11.746(2)Å c=10.3067(17)Å
α=90° β=115.940(12)° γ=90°
4-(2,6-Dichlorobenzyl)-6-phenylpyridazin-3(2<i>H</i>)-one
C17H12Cl2N2O
Acta Crystallographica Section E (2019) 75, 5 650-654
a=5.8511(6)Å b=12.5544(15)Å c=21.069(2)Å
α=90° β=92.666(8)° γ=90°
3-(4-Methoxyphenyl)-1-methyl-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H16N4O
Acta Crystallographica Section E (2019) 75, 5 638-641
a=6.5227(3)Å b=7.8979(4)Å c=30.7774(15)Å
α=90° β=95.389(2)° γ=90°
6-Methoxy-9-methyl-12-(pyridin-3-yl)-8-oxa-10,11,13,15-tetraazatetracyclo\ [7.6.1.0^2,7^.0^10,14^]hexadeca-2(7),3,5,11,13-pentaene
C19H19N5O2
Acta Crystallographica Section E (2018) 74, 3 367-370
a=17.1509(8)Å b=17.1509(8)Å c=11.9033(7)Å
α=90° β=90° γ=90°
2-Methyl-3-nitro-<i>N</i>-[(<i>E</i>)-(5-nitrothiophen-2-yl)methylidene]aniline
C12H9N3O4S
Acta Crystallographica Section E (2021) 77, 2 138-141
a=7.1335(4)Å b=11.7297(6)Å c=15.4593(7)Å
α=90° β=90° γ=90°